Richard Honkanen

Affiliations: 
University of South Alabama, Mobile, AL, United States 
Area:
Biochemistry
Google:
"Richard Honkanen"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mayer A, Derua R, Spahn E, et al. (2024) The role of liprin-α1 phosphorylation in its liquid-liquid phase separation: regulation by PPP2R5D/PP2A holoenzyme. Biorxiv : the Preprint Server For Biology
Wu CG, Balakrishnan VK, Merrill RA, et al. (2023) B56δ long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan's syndrome mutations. Proceedings of the National Academy of Sciences of the United States of America. 121: e2310727120
Smolen KA, Papke CM, Swingle MR, et al. (2023) Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades. The Journal of Biological Chemistry. 105154
Salter EA, Wierzbicki A, Honkanen RE, et al. (2023) Quantum-based modeling implies that bidentate Arg-substrate binding enhances serine/threonine protein phosphatase-2A(PPP2R5D/PPP2R1A/PPP2CA)-mediated dephosphorylation. Frontiers in Cell and Developmental Biology. 11: 1141804
Wu CG, Balakrishnan VK, Parihar PS, et al. (2023) Extended regulation interface coupled to the allosteric network and disease mutations in the PP2A-B56δ holoenzyme. Biorxiv : the Preprint Server For Biology
Shuhaibar LC, Kaci N, Egbert JR, et al. (2021) Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth. Jci Insight. 6
Papke CM, Smolen KA, Swingle MR, et al. (2021) A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth. The Journal of Biological Chemistry. 100313
D'Arcy BM, Swingle MR, Schambeau L, et al. (2019) Development of a Synthetic 3-ketosteroid Δ-dehydrogenase for the Generation of a Novel Catabolic Pathway Enabling Cholesterol Degradation in Human Cells. Scientific Reports. 9: 5969
D'Arcy BM, Swingle MR, Papke CM, et al. (2019) The Antitumor Drug LB-100 is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Catalytic Metals in the Active Site of PP5C. Molecular Cancer Therapeutics
Swingle MR, Honkanen RE. (2018) Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development. Current Medicinal Chemistry
See more...